Literature DB >> 3115639

Induction of interleukin 2 receptiveness and proliferation in resting peripheral T cells by monoclonal anti-CD3 (T3) antibodies does not require the presence of macrophages.

L A Stingl1, A Sinska, U Landesmann, J S Smolen.   

Abstract

In this study, we sought to elucidate the sequence of events by which mitogenic monoclonal anti-CD3 antibodies (anti-CD3-MoAb) initiate T cell activation. In cultures of monocyte-depleted resting T cells, two anti-CD3-MoAb, OKT3 and anti-Leu 4, induced a state of interleukin 2 (IL-2) receptiveness which culminated in T lymphocyte proliferation when recombinant IL-2 was provided. Evidence that Fc-receptor mediation by monocytes did not contribute to this mitogenesis was supported by studies showing that polyclonal F(ab')2 anti-mouse IgG Fc antibody did not alter the magnitude of the IL-2 driven T cell proliferative response, and by the use of T cells from donors whose monocytes were unable to assist in the induction of anti-Leu 4 (IgG1 subclass) initiated proliferation. Anti-CD3-MoAb, in the absence of IL-2, induced IL-2 receptor expression on purified T cells, and anti-IL 2 receptor antibodies inhibited T cell proliferation in the presence of this growth factor. Furthermore, following modulation of the CD3 molecular complex in the presence of monocytes, depletion of accessory cells rendered the modulated T cells mitogenically dependent on exogenous IL-2. IL-2 itself did not suffice to promote T cell proliferation in the absence of anti-CD3-MoAb. These results indicate that the binding of monoclonal antibody to CD3 is capable of initiating, in an accessory cell-independent manner, premitotic alterations in T cells which can culminate in proliferation when exogenous IL-2 is provided.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115639      PMCID: PMC1542681     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Cellular origin and interactions involved in gamma-interferon production induced by OKt3 monoclonal antibody.

Authors:  T W Chang; D Testa; P C Kung; L Perry; H J Dreskin; G Goldstein
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

2.  Molecular interactions in human T cell-mediated cytotoxicity to EBV II. Monoclonal antibody OKT3 inhibits a post-killer-target recognition/adhesion step.

Authors:  C D Tsoukas; D A Carson; S Fong; J H Vaughan
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

3.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

4.  OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.

Authors:  J P Van Wauwe; J R De Mey; J G Goossens
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

5.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.

Authors:  W J Leonard; J M Depper; T Uchiyama; K A Smith; T A Waldmann; W C Greene
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

6.  Characterization of autologous rosette-forming cells: a nonrestricted phenomenon.

Authors:  J S Smolen; S O Sharrow; A D Steinberg
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

7.  Responder cells in the human autologous mixed lymphocyte reaction.

Authors:  J S Smolen; T A Luger; T M Chused; A D Steinberg
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

8.  Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies.

Authors:  U Landegren; U Ramstedt; I Axberg; M Ullberg; M Jondal; H Wigzell
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

9.  Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex.

Authors:  S C Meuer; K A Fitzgerald; R E Hussey; J C Hodgdon; S F Schlossman; E L Reinherz
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

10.  T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Authors:  R J Robb; A Munck; K A Smith
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  3 in total

1.  Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens.

Authors:  J Martorell; J Font; I Rojo; R Vilella; M Ingelmo; J Vives
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  Comparison of Three CD3-Specific Separation Methods Leading to Labeled and Label-Free T Cells.

Authors:  Ronald Weiss; Wilhelm Gerdes; Rommy Berthold; Ulrich Sack; Ulrike Koehl; Sunna Hauschildt; Anja Grahnert
Journal:  Cells       Date:  2021-10-21       Impact factor: 6.600

3.  Suppressing Kv1.3 Ion Channel Activity with a Novel Small Molecule Inhibitor Ameliorates Inflammation in a Humanised Mouse Model of Ulcerative Colitis.

Authors:  Anna-Lena Unterweger; Morten Ø Jensen; Fabrizio Giordanetto; Vishwanath Jogini; Alena Rüschher; Marietta Seuß; Paula Winkelmann; Leandra Koletzko; David E Shaw; Matthias Siebeck; Roswitha Gropp; Florian Beigel; Attila Aszodi
Journal:  J Crohns Colitis       Date:  2021-11-08       Impact factor: 9.071

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.